Plenty happening in ANCA-assoc vasculitis - just a taste of recent insights into induction therapy: pulse methylpred does not improve survival but increases sepsis and diabetes, MMF similar induction rates to CYC but more relapses #EULAR2019 SP0044 from Raashid Luqmani @RheumNow https://t.co/3VhxaAPZm9 https://t.co/BdhbLSzNC1